A 38-year-old woman presents to the emergency department with a 3-day history of fever (39.2°C), myalgia, headache, and dry cough. She has no significant past medical history and is not pregnant. A rapid influenza diagnostic test (RIDT) is positive for influenza A. Her vital signs are stable and oxygen saturation is 96% on room air. What is the most appropriate next step in management?

Explanation

## Clinical Context This patient presents with classic influenza symptoms and has tested positive on rapid influenza diagnostic test (RIDT). She is within the critical 48-hour window for antiviral efficacy. ## Management Principle **Key Point:** Neuraminidase inhibitors (oseltamivir) are most effective when started within 48 hours of symptom onset and reduce illness duration by approximately 1 day and complications by ~30%. **High-Yield:** RIDT positivity in a symptomatic patient is sufficient to initiate antiviral therapy — do NOT delay for RT-PCR confirmation, as this delays treatment and reduces efficacy. ## Why Oseltamivir Now? 1. Patient is within 48-hour window (3 days is borderline but still recommended) 2. RIDT is positive (high specificity in symptomatic patients) 3. No contraindications (not pregnant, stable renal function implied) 4. Reduces symptom duration and risk of complications ## Dosing - **Standard:** Oseltamivir 75 mg orally twice daily × 5 days - **Renal impairment:** Adjust if CrCl < 30 mL/min **Clinical Pearl:** Even if >48 hours, oseltamivir is still recommended in hospitalized patients or those at high risk of complications (age >65, chronic medical conditions, immunocompromised). ## Monitoring Patient should be advised to: - Isolate for 5 days from symptom onset - Monitor for warning signs (dyspnea, altered mental status, severe chest pain) - Expect symptom improvement in 24–48 hours with treatment